Evolus, Inc. EOLS NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

57/100

3/7 Pass

SharesGrow Intrinsic Value

Evolus, Inc. (EOLS) has 20 known insider and institutional holders on record. The largest holder is Alphaeon Corp with 8,662,346 shares. Other notable holders include Alphaeon 1 LLC and Medytox Inc..

Over the last 12 months, insiders have made 26 transactions in EOLS stock — 11 buys (valued at $2.4M) and 12 sells (valued at $2.47M). Insider selling has exceeded buying during this period.

EOLS Insider Ownership

Top Holder

Alphaeon Corp

8,662,346 shares

Buys (12 mo)

$2.4M value

Sells (12 mo)

$2.47M value

12-Month Transaction Activity

Buy 42%

Sell 46%

Top Insider Holders

#	Name	Role	Shares Owned	Last Filed	Relative Size
1	Alphaeon Corp	10 Percent Owner	8,662,346	2019-06-04	100%
2	Alphaeon 1 Llc	10 Percent Owner	4,214,871	2023-02-22	49%
3	Medytox Inc.	Officer	3,381,326	2023-10-18	39%
4	Moatazedi David	See Remarks	604,700	2026-03-20	7%
5	Avelar Rui	See Remarks	427,423	2026-03-20	5%
6	Malik Vikram	Director	321,109	2026-02-19	4%
7	Jafar Michael M.	See Remarks	219,851	2021-02-01	3%
8	Beaver Sandra	Chief Financial Officer	167,089	2025-05-14	2%
9	Silvernail Lauren P	See Remarks	141,571	2022-05-18	2%
10	Muilenburg Crystal	Chief Marketing Officer	134,248	2022-03-10	2%
11	Stewart Brady	Director	134,188	2026-02-19	2%
12	Mitchell Tatjana	Chief Financial Officer	121,489	2026-02-19	1%
13	White Albert G Iii	Director	95,937	2026-02-19	1%
14	Yamagishi-dressler Tomoko	Chief Marketing Officer	89,949	2025-08-26	1%
15	Gill David N	Director	86,887	2026-02-19	1%
16	Parschauer Karah Herdman	Director	77,742	2026-02-19	1%
17	Romine Kristine	Director	23,458	2020-01-24	0%
18	Hau Bosun	Director	23,458	2020-01-24	0%
19	Farrell Peter C	Director	11,789	2023-01-31	0%
20	Blank Simone	Director	11,146	2025-03-11	0%

Recent Transactions (last 12 months)

Date	Name	Role	Type	Shares	Price	Value
2026-03-20	Moatazedi David	See Remarks	Informative Sell	13,669	$4.75	$64.93K
2026-03-20	Avelar Rui	See Remarks	Informative Sell	3,119	$4.75	$14.82K
2026-03-17	Moatazedi David	See Remarks	Informative Sell	116,720	$4.89	$570.56K
2026-03-16	Moatazedi David	See Remarks	Option Exercise (Sell)	67,489	-	-
2026-03-17	Avelar Rui	See Remarks	Informative Sell	29,996	$4.89	$146.63K
2026-03-16	Avelar Rui	See Remarks	Option Exercise (Sell)	8,804	-	-
2026-02-17	Mitchell Tatjana	Chief Financial Officer	RSU Award	121,489	-	-
2026-02-17	Stewart Brady	Director	RSU Award	45,559	-	-
2026-02-17	Malik Vikram	Director	RSU Award	45,559	-	-
2026-02-17	Moatazedi David	See Remarks	RSU Award	457,541	$4.39	$2.01M
2026-02-17	Parschauer Karah Herdman	Director	RSU Award	45,559	-	-
2026-02-17	Avelar Rui	See Remarks	RSU Award	94,913	-	-
2026-02-17	White Albert G Iii	Director	RSU Award	45,559	-	-
2026-02-17	Gill David N	Director	RSU Award	45,559	-	-
2025-12-22	Moatazedi David	See Remarks	Informative Sell	10,539	$7.15	$75.36K
2025-12-22	Avelar Rui	See Remarks	Informative Sell	2,261	$7.15	$16.17K
2025-09-08	Mitchell Tatjana	Chief Financial Officer	RSU Award	104,603	-	-
2025-09-08	Mitchell Tatjana	Officer	Unknown	-	-	-
2025-08-22	Yamagishi-dressler Tomoko	Chief Marketing Officer	Informative Sell	5,722	$7.51	$42.97K
2025-08-15	Stewart Brady	Director	Informative Buy	30,000	$6.82	$204.49K
2025-06-16	Moatazedi David	See Remarks	Informative Sell	16,582	$9.89	$164.05K
2025-06-13	Moatazedi David	See Remarks	Informative Sell	111,323	$10.05	$1.12M
2025-06-09	White Albert G Iii	Director	Informative Buy	20,000	$9.45	$189K
2025-05-13	Beaver Sandra	Chief Financial Officer	Informative Sell	6,494	$10.02	$65.07K
2025-05-12	Moatazedi David	See Remarks	Informative Sell	15,787	$9.87	$155.76K